NERV Research and Charts

NERV - Minerva Neurosciences Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-16 (Delayed quote data 2025-01-02)

Last 2.30	Change ⇑ +0.08 (+3.60%)	Volume 5,744
	Open 2.22	High 2.30	Low 2.21

8EMA (Daily) 2.25	40EMA (Daily) 2.28	50EMA (Daily) 2.31	STO (Daily) 63.561	MACD Hist (Daily) 0.034
8EMA (Weekly) 2.296	40EMA (Weekly) 3.01	50EMA (Weekly) 3.27	STO (Weekly) 21.981	MACD Hist (Weekly) 0.084


Company Profile
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It primarily focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.